PH31669A - Bcrf1 proteins as inhibitors of interferon-gamma. - Google Patents

Bcrf1 proteins as inhibitors of interferon-gamma.

Info

Publication number
PH31669A
PH31669A PH41744A PH41744A PH31669A PH 31669 A PH31669 A PH 31669A PH 41744 A PH41744 A PH 41744A PH 41744 A PH41744 A PH 41744A PH 31669 A PH31669 A PH 31669A
Authority
PH
Philippines
Prior art keywords
gamma
interferon
inhibitors
bcrf1
proteins
Prior art date
Application number
PH41744A
Other languages
English (en)
Inventor
Kevin W Moore
Robert A Kastelein
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PH31669A publication Critical patent/PH31669A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/141—Interleukin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PH41744A 1989-12-20 1990-12-18 Bcrf1 proteins as inhibitors of interferon-gamma. PH31669A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45393189A 1989-12-20 1989-12-20

Publications (1)

Publication Number Publication Date
PH31669A true PH31669A (en) 1999-01-18

Family

ID=23802631

Family Applications (1)

Application Number Title Priority Date Filing Date
PH41744A PH31669A (en) 1989-12-20 1990-12-18 Bcrf1 proteins as inhibitors of interferon-gamma.

Country Status (27)

Country Link
US (2) US5627155A (cs)
EP (1) EP0506836B1 (cs)
JP (1) JP2648236B2 (cs)
KR (1) KR960015199B1 (cs)
CN (1) CN1057012C (cs)
AT (1) ATE112317T1 (cs)
AU (1) AU7899694A (cs)
CA (1) CA2071907C (cs)
CZ (1) CZ283049B6 (cs)
DE (1) DE69013011T2 (cs)
DK (1) DK0506836T3 (cs)
ES (1) ES2064082T3 (cs)
FI (1) FI104883B (cs)
HK (1) HK185396A (cs)
HU (1) HU215909B (cs)
IE (1) IE72203B1 (cs)
IL (1) IL96715A0 (cs)
MX (1) MX9203409A (cs)
MY (1) MY107449A (cs)
NO (1) NO305703B1 (cs)
NZ (1) NZ236512A (cs)
OA (1) OA09703A (cs)
PH (1) PH31669A (cs)
PT (1) PT96231B (cs)
SK (1) SK635190A3 (cs)
WO (1) WO1991009127A1 (cs)
ZA (1) ZA9010188B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
JPH04505019A (ja) * 1989-10-23 1992-09-03 シェリング・コーポレーション ガンマインターフェロンのポリペプチド性阻害剤
CA2100553A1 (en) * 1991-01-16 1992-07-17 Paulo J. M. Vieira Treatment of neoplastic disease with interleukin-10
US6106823A (en) 1991-01-16 2000-08-22 Schering Corporation Treatment of neoplastic disease with interleukin-10
US5833976A (en) * 1991-08-06 1998-11-10 Schering Corporation Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity
ATE187336T1 (de) * 1991-08-06 1999-12-15 Schering Corp Verwendung von interleukin-10 analogen oder antagonisten zur behandlung von endotoxin- oder superantigen induzierter toxizität
US6008327A (en) 1992-03-13 1999-12-28 Akzo Nobel, N.V. Peptides and nucleic acid sequences related to the Epstein Barr virus
PT574048E (pt) * 1992-03-13 2002-12-31 Organon Teknika Bv Peptidos e sequencias de acido nucleico relacionados com virus de epstein-barr
WO1993018783A1 (en) * 1992-03-20 1993-09-30 Schering Corporation Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist
EP0726315B1 (en) * 1993-07-23 2001-10-17 Hans Prof. Dr. Wolf Epstein-Barr virus DNA sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests
US5616724A (en) * 1996-02-21 1997-04-01 Cephalon, Inc. Fused pyrrolo[2,3-c]carbazole-6-ones
JP2001512830A (ja) * 1997-08-08 2001-08-28 ニューバイオティックス インコーポレイテッド 生物療法耐性および化学療法耐性を克服するための方法および組成物
CN104159919A (zh) 2011-11-23 2014-11-19 安姆根有限公司 使用抗干扰素γ抗体的治疗方法
WO2022016509A1 (zh) * 2020-07-24 2022-01-27 阎忠扬 一种用以筛选药物的方法，以及该药物用于治疗牛皮癣的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583564D1 (de) * 1984-08-23 1991-08-29 Hans Joachim Wolf Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
US5256768A (en) * 1985-12-13 1993-10-26 The Johns Hopkins University Expression of antigenic Epstein-Barr virus polypeptides in bacteria and their use in diagnostics

Also Published As

Publication number Publication date
CZ283049B6 (cs) 1997-12-17
MX9203409A (es) 1992-07-01
ES2064082T3 (es) 1995-01-16
AU652732B2 (en) 1994-09-08
WO1991009127A1 (en) 1991-06-27
US5736390A (en) 1998-04-07
OA09703A (en) 1993-08-30
DK0506836T3 (da) 1994-11-28
FI922770A0 (fi) 1992-06-16
MY107449A (en) 1995-12-31
HUT65369A (en) 1994-05-02
IE904588A1 (en) 1991-07-03
IE72203B1 (en) 1997-04-09
PT96231B (pt) 1998-09-30
JPH05503846A (ja) 1993-06-24
CN1057012C (zh) 2000-10-04
NO922456D0 (no) 1992-06-19
NZ236512A (en) 1997-07-27
IL96715A0 (en) 1991-09-16
PT96231A (pt) 1991-09-30
SK279830B6 (sk) 1999-04-13
NO922456L (no) 1992-06-19
HK185396A (en) 1996-10-11
HU9202075D0 (en) 1992-10-28
ZA9010188B (en) 1991-08-28
FI104883B (fi) 2000-04-28
AU7899694A (en) 1995-02-09
AU7063691A (en) 1991-07-18
EP0506836B1 (en) 1994-09-28
JP2648236B2 (ja) 1997-08-27
CA2071907C (en) 2000-08-08
US5627155A (en) 1997-05-06
NO305703B1 (no) 1999-07-12
CZ635190A3 (en) 1997-09-17
EP0506836A1 (en) 1992-10-07
DE69013011D1 (de) 1994-11-03
CN1052608A (zh) 1991-07-03
DE69013011T2 (de) 1995-02-23
SK635190A3 (en) 1999-04-13
ATE112317T1 (de) 1994-10-15
CA2071907A1 (en) 1991-06-21
KR960015199B1 (ko) 1996-11-01
FI922770A (fi) 1992-06-16
HU215909B (hu) 1999-03-29

Similar Documents

Publication Publication Date Title
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
OA09703A (en) bcrf1 proteins as inhibitors of interferon-gamma
ES8602768A1 (es) Un procedimiento para la preparacion de nuevas n-(heterociclil biciclo)-4-piperidinaminas.
HK1040493A1 (en) Use of mammalian cytokine synthesis inhibitory factor in manufacturing a medicament.
IL119461A (en) 4,7-disubstituted -7H-pyrrolo ¬2, 3-d¾pyrimidines
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
HU9201799D0 (en) New 2-amino-5-ciano-1,4-dihydropiridine-derivatives, process for their use and their use as medicaments
EP0273310A3 (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
ES8900164A1 (es) Un procedimiento para preparar oxadiazolil 1-4-dihidropiridinas.
MX9700113A (es) Amido-quinoxalindionas novedosas, su preparacion y uso.
TW372873B (en) A novel anti-neoplastic cytokine
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
HUT39599A (en) Process for producing compositions stimulating growth of hair
WO1990010006A3 (de) NEUE β-METHOXYACRYLATE, IHRE HERSTELLUNG UND VERWENDUNG